Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-08-29

Clinical Trial Update: Phase II Study of Albumin Bound Paclitaxel With 5-FU and CF as Second Line in Taxanes Naive Advanced Gastric Cancer [Phase 2]

View source ↗

Summary

Phase II trial evaluating nab-paclitaxel with 5-FU and CF as second-line therapy in taxane-naive advanced gastric cancer. The information comes from a ClinicalT…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 5-Fluorouracil (5-FU)
  • CF (cisplatin + 5-FU) (cisplatin + 5-FU)
  • Nab-paclitaxel (paclitaxel protein-bound)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Gastric Caner | Phase 2 | Status: UNKNOWN